Insys Therapeutics (INSY)

9.15 -0.30 (3.17%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/1/18 *Est.)

Latest Headlines

INSYS Therapeutics to Present at Janney Healthcare Conference September 14, 2018 2:00 PM - Globe NewsWire INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Expand Collaboration to Include Clinical Study of Cannabidiol in Early Psychosis September 4, 2018 6:00 AM - Globe NewsWire Pre-Open Movers 08/30: (KTWO) (SIG) (INSY) (Higher) (PDCO) (ANF) (DLTR) Lower (More...) August 30, 2018 8:47 AM - StreetInsider Insys Therapeutics (INSY) Granted Fast Track Designation by FDA for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis August 30, 2018 6:05 AM - StreetInsider FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis August 30, 2018 6:00 AM - Globe NewsWire Form 4 Insys Therapeutics, Inc. For: Aug 07 Filed by: BOHLEN ELIZABETH August 9, 2018 4:18 PM - SEC Filing Form 3 Insys Therapeutics, Inc. For: Aug 07 Filed by: BOHLEN ELIZABETH August 9, 2018 4:17 PM - SEC Filing Form 10-Q Insys Therapeutics, Inc. For: Jun 30 August 9, 2018 2:51 PM - SEC Filing INSYS Therapeutics (INSY) PT Raised to $9 at RBC Capital August 9, 2018 8:35 AM - StreetInsider INSYS Therapeutics Appoints Elizabeth Bohlen to Board of Directors August 9, 2018 7:00 AM - Globe NewsWire Form 8-K Insys Therapeutics, Inc. For: Aug 08 August 8, 2018 5:25 PM - SEC Filing Insys Therapeutics (INSY) Misses Q2 EPS by 17c August 8, 2018 4:18 PM - StreetInsider INSYS Therapeutics Reports Second Quarter 2018 Results August 8, 2018 4:15 PM - Globe NewsWire Insys Therapeutics (INSY) Reaches Agreement in Principle to Settle DOJ Investigation August 8, 2018 7:16 AM - StreetInsider INSYS Therapeutics Reaches Agreement in Principle to Settle Department of Justice Investigation August 8, 2018 7:00 AM - Globe NewsWire Form 4 Insys Therapeutics, Inc. For: Aug 07 Filed by: Long Andrew G August 7, 2018 3:11 PM - SEC Filing Insys Therapeutics (INSY) Falls 8% Following CRL July 27, 2018 12:59 PM - StreetInsider Insys Therapeutics (INSY) Receives CRL from FDA on Buprenorphine NDA July 27, 2018 12:51 PM - StreetInsider INSYS Therapeutics Receives Complete Response Letter from FDA for Buprenorphine NDA July 27, 2018 12:50 PM - Globe NewsWire INSYS Therapeutics to Report Second Quarter 2018 Results on Aug. 8 July 25, 2018 8:00 AM - Globe NewsWire U.S. to narrow opioid bribe case against Insys founder, others July 24, 2018 1:13 PM - StreetInsider U.S. judge questions scope of indictment against Insys founder July 17, 2018 1:48 PM - StreetInsider Full Article List